בשל "הגנת זכויות יוצרים" מובא להלן קישור לתקציר המאמר. לקריאתו בטקסט מלא, אנא פנה/י לספרייה הרפואית הזמינה לך.  

The risk of fetal atrioventricular block in anti-Ro/SSA antibody–exposed pregnancies with no previous affected offspring is approximately 2%. 

A high antibody titer is necessary but not sufficient for atrioventricular block, and specific antibody titers do not predict risk. 

However, there are no data on the negative predictive value of antibody titer to identify pregnancies at low risk of fetal atrioventricular block, and may not require surveillance.

This study aimed to define anti-Ro52 and anti-Ro60 antibody thresholds for the identification of fetuses unlikely to develop atrioventricular block using clinically validated and research laboratory tests.